在酒精治疗环境中出现并发症的服务用户在临床研究获取方面的不公平:集中民族学研究的发现
Sofia Hemrage1, Stephen Parkin2,3, Nicola J Kalk2,4
1Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. sofia.hemrage@kcl.ac.uk.
International journal for equity in health
|May 22, 2024
概括
个人,组织和结构层面的障碍限制了酒精使用障碍和肝脏疾病患者的研究访问. 解决这些问题对于减少健康不平等和提高治疗效率至关重要.
科学领域:
- 临床研究 临床研究
- 医疗保健服务研究 医疗服务研究
- 健康 公平 卫生 公平
背景情况:
- 医疗保健政策旨在改善服务不足群体的获得,但系统性障碍仍然存在.
- 在临床研究中缺乏代表性,扩大了健康不平等.
- 识别特定患者群体的研究获取障碍至关重要.
研究的目的:
- 识别临床研究获取的个人,组织和结构障碍.
- 专注于患有并发性酒精使用障碍和酒精相关肝病的患者.
- 了解影响参与临床环境内研究的因素.
主要方法:
- 聚焦的民族学方法.
- 使用现场笔记和患者采访进行代-诱导数据收集.
- 数据分析的框架方法,在微,中和宏观层面确定主题.
主要成果:
- 微层面的障碍包括与酒精有关的问题 (脑病,戒断) 和与酒精无关的因素.
- 超级层面的障碍包括人员/资源压力和对设施的熟悉度.
- 宏观层面的障碍包括社会经济因素 (生活成本危机) 和工业行动.
结论:
- 由外部危机加剧的个人,组织和结构障碍,限制了服务不足群体的研究机会.
- 酒精使用障碍和肝病患者的研究参与有限,加剧了治疗差距和健康不平等.
- 解决多方面的障碍对于公平的研究包容性和有效的基于证据的干预措施至关重要.
关键词:
访问 访问 访问 访问 访问酒精使用障碍 饮酒障碍与酒精有关的肝脏疾病障碍物 这些障碍物临床护理 临床护理伴随性疾病 伴随性疾病专注于民族学的民族学.不公平 不公平 不公平研究研究研究研究研究研究.服务用户是服务的用户.更多相关视频
相关概念视频
Nursing Ethical Principles II
955
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
955
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Strategies for Assessing and Addressing Confounding
93
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
93
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


